| abstract |
The compound: ** Formula ** or its pharmaceutically acceptable salt, for use in the treatment of a cognitive disorder that is selected from the group consisting of an agnosia, an amnesia, an aphasia, an apraxia, a delirium, a dementia, and a learning disorder |